International Clinical Trial: A Phase 1 Study to Evaluate the Safety and Immunogenicity of the COVID-19 Preventive Vaccine 'GC4006A' in Healthy Adults

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (KCT0012333) titled 'A Phase 1 Study to Evaluate the Safety and Immunogenicity of the COVID-19 Preventive Vaccine 'GC4006A' in Healthy Adults' on July 27.

Study Type: Interventional Study

Study Design: Primary Purpose : Prevention, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Caregiver, Allocation : RCT

Primary Sponsor: Koera University Guro Hospital

Condition:

Codes for special purposes

Intervention: Biological/Vaccine, Non-Stem Cell : Administer a single dose of each IP into the deltoid muscle. - Experimental (GC4006A): 0.15mL/0.3mL/0.5mL - Placebo comparator (Normal Saline):...